Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating Activities
Net loss	$ (7,394)	$ (39,399)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation, amortization and accretion	4,505	5,352
Impairment expense	2,600	19,453
Stock-based compensation expense	4,244	2,748
Gain on derivative warrant liabilities	(3,594)
Loss from contingent consideration	232	496
Amortization of senior debt (premium) discount	315	(326)
(Gain) on sale of equipment	(42)	(50)
Inventory write-down	82	349
Other noncash adjustments	9	(86)
Changes in operating assets and liabilities:
Accounts receivable	(3,834)	5,186
Inventory	(2,183)	(568)
Prepaid expenses and other current assets	(4,606)	(1,896)
Accounts payable and other	(838)	(3,307)
Accrued liabilities	(1,008)	(616)
Other operating assets and liabilities, net	(76)	51
Net cash used in operating activities	(11,588)	(12,613)
Investing Activities
Contingent consideration payment	(5)	(3,109)
Other investing activities	42	(28)
Net cash provided by (used in) investing activities	37	(3,137)
Financing Activities
Proceeds from issuance of stock and warrants	11,573	4,825
Payment of stock issuance costs	(1,000)	(172)
Payment made to fixed payment arrangement	(2,433)	(2,746)
Net proceeds received (payments made on) short-term line of credit	3,616	(775)
Other financing activities	(64)	(6)
Net cash provided by financing activities	11,692	1,126
Net change in cash, cash equivalents and restricted cash	141	(14,624)
Cash, cash equivalents and restricted cash at beginning of period	19,360	49,901
Cash and cash equivalents at end of period	19,501	35,277
Supplemental cash flow data
Cash paid for interest	$ 2,021	2,356
Non-cash investing and financing activities:
Other noncash investing and financing activities		$ 29